Evolent Health (EVH) Misses Q3 EPS by 24c, provides guidance

Evolent Health (NYSE: EVH) reported Q3 EPS of $0.04, $0.24 worse than the analyst estimate of $0.28. Revenue for the quarter came in at $621.4 million versus the consensus estimate of $627.17 million.

GUIDANCE:

Evolent Health sees FY2024 revenue of $2.55-2.575 billion, versus the consensus of $2.577 billion.

For earnings history and earnings-related data on Evolent Health (EVH) click here.

You May Also Be Interested In

• Geberit AG (GEBN:SW) (GBERY) PT Raised to CHF712 at Jefferies
• EU proposes to curb Airbnb and short-term rentals amid housing shortage
• JPMorgan Downgrades Woolworths Holdings Ltd (WHL:SJ) to Underweight